Umoja and TreeFrog team up to overcome challenges facing ex vivo allogeneic therapies 14-Jun-2022 By Jane Byrne Umoja Biopharma and TreeFrog Therapeutics have formed an alliance to address challenges facing ex vivo allogeneic therapies in immuno-oncology, including issues scaling up production to reach all patients.